02/05/2024
6:53 PM | Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
| Form SC 13D/A | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/31/2024
11:15 PM | Navidea Biopharmaceuticals (Filer)
| Form EFFECT | |
01/26/2024
4:26 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
|
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form POS AM | |
01/26/2024
4:27 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/26/2024
4:28 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8 POS | |
01/16/2024
12:53 PM | Navidea Biopharmaceuticals (Subject)
NYSE AMERICAN LLC (Filed by)
| Form 25-NSE | |
12/22/2023
6:54 PM | Navidea Biopharmaceuticals (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
12/21/2023
2:32 PM | Navidea Biopharmaceuticals (Subject)
Scott John K Jr. (Filed by)
| Form SC 13D/A | |
12/05/2023
5:26 PM | Navidea Biopharmaceuticals (Issuer)
Scott John K Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/01/2023
10:49 AM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/20/2023
5:43 PM | Moss Dana J (Reporting)
Navidea Biopharmaceuticals (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/20/2023
5:10 PM | Navidea Biopharmaceuticals (Issuer)
Stefanelli Jill (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/16/2023
3:55 PM | Navidea Biopharmaceuticals (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/13/2023
1:58 PM | Navidea Biopharmaceuticals (Filer)
| Form DEFA14A | |
Free NAVB Stock Alerts